Welcome to your DXC-curated resource for industry news

Personalized care pathways
 

Personalized care pathways are linked to better outcomes and improved patient safety. In addition, they can promote greater health equity in communities.

To learn more, Becker’s Hospital Review recently spoke about personalized care pathways with two strategists from DXC.

Dr. Urvashi Pathak
Industry Strategist, Provider
DXC Technology

Kimberly MacDowell
Vice President and General Manager
Commercial Healthcare and Life Sciences
DXC Technology

 

Regulatory and compliance
 

Four key challenges in sustaining compliance in the medical device industry (article in Today’s Medical Developments)


DXC perspective

To meet the challenges of sustaining compliance in the medical device industry, it is imperative to create future-resistant data and cybersecurity strategies. Having structured, collaborative and cross-functional data and cybersecurity practices is important, especially to prepare for data-related regulations and global standards that continue to change and to implement risk-based supplier management. To tackle complexity, leaders can explore adopting AI or machine learning tools to automate data audits, security and compliance and free up resources to focus on more strategic tasks.

Gerson Benker
Industry Strategist, Medical Device
DXC Technology

This DXC-sponsored Reuters Events paper examines the need and opportunities for automation in the pharmaceutical industry.

The way life sciences businesses and regulators collaborate to bring safe new therapies to market is ripe for transformation. Digitization and automation offer speedier creation, submission and querying of the volumes of documentation inherent in research and commercialization.

 

Disruptive technologies in life sciences
 

Four technologies set to disrupt the life sciences — and how pharmaceutical companies can prepare (article from Forbes.com)


DXC perspective

Innovation is at the heart of the life sciences business. The industry is poised to make significant leaps in bringing breakthrough therapeutics to market faster with disruptive tech such as quantum computing, blockchain, 3D printing, IoT and natural language processing. Underpinning the success of all such technology initiatives is the maturity of data technologies (big data, cloud, integration, collaboration) and what DXC refers to as data metabolism — the ability to serve up relevant data and insights at the right time and speed to the right people.

Ankur Chadha
Industry Strategist, Life Sciences
DXC Technology

 

Interoperability: Smart use of data for better outcomes
 

The power of sharing information and tapping into the data generated across entities that touch healthcare is limitless. Instead of looking at adapting to the bulk FHIR API standard merely to comply with mandates, healthcare providers and payers should look at unleashing the full potential of this information sharing. As the post-pandemic era takes shape, we realize the critical role of insights that can be underpinned by seamless data exchange, and its role in providing the right insights for patient populations to enable the right care and outcomes. DXC believes that organizations should not just solidify their use of FHIR, but continue to accelerate their use of data science, AI and machine learning to enhance care delivery.

Dr. Urvashi Pathak
Industry Strategist, Provider
DXC Technology

 

Health equity
 

While mobile healthcare has been around for years, the pandemic highlighted its potential to address health equity concerns. As emphasized throughout the article, a key component to the success of mobile clinics is a high-performing, well-planned community outreach program. Bringing healthcare into a community or into an individual’s home can be invasive, and it requires a lot of trust. Providers are challenged with the analytical components of mobile healthcare, such as tracking ER cost reductions that result from providing preventive care, as well as the soft skills of engaging with prospective patients on terms very different from what providers may be used to. While it can be a tough nut to crack, it’s the way to encourage early detection, prevention and access to healthcare.

Kelly Vroom
Industry Strategist, Provider
DXC Technology

Subscribe here to stay up-to-date on topics surrounding the challenges and solutions unique to today’s Healthcare & Life Sciences organizations.


 
Download a copy of this issue of Healthcare Insights here.

 

Events
 
Becker’s Health IT + Digital Health + RCM Annual Meeting: The Future of Business and Clinical Technologies

October 4 – 7, 2022 | Navy Pier | Chicago

As an event sponsor, DXC Technology will host an intimate session, “DXC Technology executive roundtable: Data — the beating heart of the healthcare ecosystem” on October 5, at 12 – 1 p.m. CT. This discussion will focus on how to use data to improve healthcare delivery — patient experience, health outcomes, financial outcomes and more. Our esteemed customer panelists will offer insights on how a wholesome view of data provides an evidence-based rationale to executives to help develop effective business strategies. Learn more.

To learn more about how DXC helps healthcare organizations modernize, visit us at dxc.com/healthcare or contact us .

Connect with us